BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29248455)

  • 1. A Large Set of miRNAs Is Dysregulated from the Earliest Steps of Human Hepatocellular Carcinoma Development.
    Sulas P; Di Tommaso L; Novello C; Rizzo F; Rinaldi A; Weisz A; Columbano A; Roncalli M
    Am J Pathol; 2018 Mar; 188(3):785-794. PubMed ID: 29248455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
    Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
    Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
    Fittipaldi S; Vasuri F; Bonora S; Degiovanni A; Santandrea G; Cucchetti A; Gramantieri L; Bolondi L; D'Errico A
    Dig Dis Sci; 2017 Sep; 62(9):2397-2407. PubMed ID: 28639131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
    Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY
    Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs involved with hepatocellular carcinoma (Review).
    Mao B; Wang G
    Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
    Gailhouste L; Ochiya T
    Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
    Chen E; Xu X; Liu R; Liu T
    Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
    Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
    BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma.
    Augello C; Vaira V; Caruso L; Destro A; Maggioni M; Park YN; Montorsi M; Santambrogio R; Roncalli M; Bosari S
    Liver Int; 2012 May; 32(5):772-82. PubMed ID: 22429613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the typical miRNAs and target genes in hepatocellular carcinoma.
    Han K; Li J; Zhao H; Liang P; Huang X; Zheng L; Li Y; Yang T; Wang L
    Mol Med Rep; 2014 Jul; 10(1):229-35. PubMed ID: 24789420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification.
    Roncalli M; Roz E; Coggi G; Di Rocco MG; Bossi P; Minola E; Gambacorta M; Borzio M
    Hepatology; 1999 Nov; 30(5):1174-8. PubMed ID: 10534338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
    Petrelli A; Perra A; Schernhuber K; Cargnelutti M; Salvi A; Migliore C; Ghiso E; Benetti A; Barlati S; Ledda-Columbano GM; Portolani N; De Petro G; Columbano A; Giordano S
    Oncogene; 2012 Oct; 31(42):4517-26. PubMed ID: 22249248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
    Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
    Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
    Um TH; Kim H; Oh BK; Kim MS; Kim KS; Jung G; Park YN
    J Hepatol; 2011 May; 54(5):939-47. PubMed ID: 21145824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
    Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
    Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules.
    Luo Q; Zhang Y; Wang N; Jin G; Jin H; Gu D; Tao X; Huo X; Ge T; Cong W; Wang C; Qin W
    Oncotarget; 2015 Mar; 6(9):6989-99. PubMed ID: 25749520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis.
    Wong CM; Wong CC; Lee JM; Fan DN; Au SL; Ng IO
    Hepatology; 2012 May; 55(5):1453-61. PubMed ID: 22135159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
    Gatto A; De Gaetano AM; Giuga M; Ciresa M; Siciliani L; Miele L; Riccardi L; Pizzolante F; Rapaccini GL; Gasbarrini A; Giuliante F; Vecchio FM; Pompili M; Bonomo L
    Abdom Imaging; 2013 Aug; 38(4):736-44. PubMed ID: 22986351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.